Cerebral artery air embolism following an esophagogastroscopy: A case report
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Cerebrovascular events during endoscopy are uncommon. Air embolism should be considered in the differential diagnosis of any stroke, particularly if it develops during or after an endoscopic procedure. We report this unusual complication in a woman who had a cerebral artery air embolism during an esophagogastroscopy procedure.
Case report. An 80-year-old woman presented with a history of progressive dysphagia, initially for solid foods and later for liquids, and severe weight loss during the previous 6 months. She was taking enalapril for hypertension. Initial investigations revealed the presence of a malignant stricture in the esophagus. She underwent an elective fiberoptic endoscopy under conscious sedation, which confirmed a malignant stricture at the esophagogastric junction, along with a small esophagotracheal fistula. Multiple small biopsies were performed, confirming the presence of esophageal carcinoma. Her level of consciousness deteriorated immediately following the procedure. She became unresponsive, but remained hemodynamically stable. Examination revealed a left hemiparesis involving the face, arm, and leg, with flexion of the right upper limb in response to pain. An emergent unenhanced CT scan of the head revealed parenchymal air in the right hemisphere (figure). Right-sided sulci were effaced, which was suggestive of an acute right middle cerebral artery infarct. Cerebral air embolism was diagnosed. She was treated conservatively with 100% oxygen therapy. A transthoracic echocardiogram with bubble contrast showed no evidence of a right-to-left intracardiac shunt. She was discharged from the hospital in a vegetative state 2 weeks after admission.
Discussion. Cerebral air embolism may occur with barotrauma 1 and during neurosurgical procedures, 2 especially when performed in a sitting position. This also has been reported as a complication of cardiac catheterization, as well as in other diagnostic andtherapeutic procedures. 3 A few cases have been reported in the absence of intracardiac defects. Penetrating duodenal ulcers may form fistulas with colon, pancreatic or bile duct, or aorta. Other cases have been reported with duodenocaval fistulas after trauma and local radiation. 4 Because of unique hepatic venous drainage, systemic air embolism is uncommon with gastrointestinal endoscopy procedures. Venous air embolism occurs only when the liver is bypassed, e.g., with portosystemic shunts in portal hypertension. Arterial air embolism is even more rare because of capillary filtration in the lungs. In certain circumstances, this filter is bypassed through a right-to-left intracardiac shunt. 5 However, in our patient, such a shunt was not found. A small tracheoesophageal fistula around the stricture was seen. There have been reports of a fatal cerebral arterial gas embolism caused by a large venous gas embolism, though no intracardiac defects or shunt mechanisms could be demonstrated. 3 An alternative mechanism for paradoxic air embolism-intrapulmonary shunts as well as transcapillary route with large air emboli-has been proposed. 6 This probably best explains the mechanism in our patient.
The neurologic manifestations are myriad and include altered consciousness, seizures, and focal deficit. CT scanning is valuable in detecting this if performed early, as IV air is rapidly absorbed and delays would result in a failure of diagnosis. CNS dysfunction results from mechanical obstruction of arterioles, leading to cerebral ischemia and the thrombotic-inflammatory response of airinjured epithelium. This results in a transient decline of cerebral blood flow and neural function. Treatment should be started as soon as there is a strong clinical suspicion for the diagnosis, including the removal of the air source, 100% oxygen by face mask, and hyperbaric oxygen. The aim of this treatment is to rapidly reduce the volume of air embolus. Recent experimental data suggest that agents with antithrombotic and antiinflammatory properties may be of potential benefit when given prophylactically in subjects at risk for cerebral air embolism. 5, 6 From 1,2 Accordingly, immunosuppressive therapy has been employed in antiphospholipid antibody (aPL)-associated chorea. [3] [4] [5] We report the correlation between clinical symptoms, laboratory activity of aPL, and striatal hypermetabolism in 18 F-fluorodeoxyglucose (FDG) PET in a patient with aPL-associated hemichorea. This patient was successfully treated with low-dose methotrexate.
Case report. A 41-year-old right-handed woman developed involuntary movements of the left hand in June 1999. Within 2 weeks, the symptoms progressed to uncontrollable jerks of the left arm and leg, with clumsiness of finger movements, twitching of the left face with squeezing of the eye, and speech difficulties due to clumsiness of the tongue. She was unable to continue working. Her medical history included moderate hypertension treated with losartan 50 mg per day, hysterectomy, and cigarette smoking (12 pack-years). Family history of movement disorders was negative.
A cranial MRI revealed no ischemic lesion. CSF, EEG, intraand extracranial DCI, and ophthalmologic examination results were normal. Tests for lupus anticoagulant (LA) were positive, with increased activated partial thromboplastin time (aPTT) (38.7 s; normal, 21.0 to 36.0 s) and dilute Russell viper venom time ratio (dRVVT-ratio) (2.2; normal, Ͻ1.2); the anticardiolipin antibody titer (IgG) (aCL-IgG) was elevated (86.0 U/mL; normal, Ͻ18 U/mL). All other laboratory results including platelet count, complement factor 3 and 4, anti-ds-DNA antibodies, antinuclear antibodies, HIV antibodies, treponema pallidum hemagglutination assay (serum and CSF), acanthocytes, serum copper and ceruloplasmin, and thyroid function were normal. A preliminary diagnosis of aPL-associated chorea was made.
Six weeks after the first manifestation of chorea, treatment was initiated with low-dose methotrexate, 20 mg orally once per week, which led to a rapid improvement. After 4 weeks of continuous medication, choreatic movements were no longer detectable and the laboratory follow-up showed an improved result for aCLIgG (55.7 U/mL) and a downward trend of LA (aPTT 34.5 s; dRVVT-ratio 1.7).
Methotrexate treatment was discontinued after 9 weeks. Eight days after the last intake, the patient again noticed involuntary movements of the left hand and foot. Neurologic examination 12 days after the last methotrexate intake confirmed a mild to moderate relapse of left-sided hemichorea. Laboratory results showed increased LA (aPTT 39.5 s; dRVVT-ratio 1.9) and aCL-IgG (75.2 U/mL). An FDG PET performed to study striatal hypermetabolism revealed an increase of FDG uptake in the right caudate nucleus as compared with the left side (6.36 Ϯ 1.5%; p Ͻ 0.05) (figure).
Medication was started again at 20 mg methotrexate per week. After 2 weeks, choreatic movements were no longer detectable. After 6 weeks of continuous medication, FDG PET revealed no difference between FDG uptake values of the left and right caudate nucleus. The laboratory follow-up showed a downward trend of dRVVT-ratio (1.7) and aCL-IgG (67.3 U/mL), whereas aPPT was nearly unchanged (42.0 s).
Discussion. This case of aPL-associated hemichorea documents an association between intensity of choreatic symptoms, laboratory activity of aPL, striatal hypermetabolism, and immunosuppressive therapy with methotrexate. Our results are consistent with earlier suggestions that aPL-associated chorea is caused by an immune-mediated excitatory effect of aPL resulting in striatal hypermetabolism measurable by PET, rather than a consequence of ischemic lesions in the basal ganglia. 5, 6 Chorea associated with aPL in adults has been reported in SLE, lupus-like syndrome, and PAPS. 3 In patients who do not fulfill the criteria of the American College of Rheumatologists for these disorders, as in our case, chorea might be an early symptom of SLE or PAPS, antedating the disease for several years, 3 or the only manifestation of aPL.
A search of the literature revealed high-dose corticosteroids, cyclophosphamide, and combinations of the two as the most frequently used medication in aPL-associated chorea. The dramatic response to oral application of low-dose methotrexate, however, demonstrates that treatment with methotrexate alone may provide a reasonable and effective alternative. 
